One of the USA’s largest compounders, Hims & Hers, has announced the acquisition of a peptide facility in California.

Mitsubishi Tanabe Pharma (MTPC) today announced that the European Medicines Agency (EMA) has accepted for review the ...

Spanish dermatology company Almirall was trading 4% higher on Monday afternoon after presenting its full-year 2024 financial ...

The US Food and Drug Administration (FDA) late Friday revealed it has approved Ctexli (chenodiol) for the treatment of ...

Earlier this month, the Norwegian government launched the cancer strategy Joint Efforts Against Cancer, with five national ...

Swiss generics and biosimilars major Sandoz has announced the launch of Pyzchiva (ustekinumab-ttwe) in the USA. From today, ...

US antivirals giant Gilead Sciences recently announced that the US Food and Drug Administration (FDA) has accepted its New ...

Japanese drug major Shionogi announced that Jeil Pharmaceutical, its partner in South Korea, has obtained marketing approval ...

Last week’s significant news was dominated by licensing deals and mergers and acquisitions. US biotech giant Biogen entered ...

US drugmaker Cosette Pharmaceuticals has entered into a definitive agreement to acquire all the outstanding shares of ...

Binnopharm Group, one of Russia’s leading drugmakers, which is controlled by the Russian financial conglomerate AFK Sistema, ...

Gilead Sciences’ seladelpar has won conditional marketing authorization to treat primary biliary cholangitis (PBC) alongside ...